1030P Phase I, first-in-human trial evaluating the STING agonist BI 1387446 alone and in combination with ezabenlimab in solid tumors

Authors:
  • ECE. Calvo
    E. Calvo
  • EGE. Garralda
    E. Garralda
  • GAG. Alonso
    G. Alonso
  • VGV. Gambardella
    V. Gambardella
  • EPE.E. Parkes
    E.E. Parkes
  • JTJ. Thompson
    J. Thompson
  • RLR. Latek
    R. Latek
  • PSP. Sikken
    P. Sikken
  • MSM. Schmohl
    M. Schmohl
  • KHK.J. Harrington
    K.J. Harrington
Publisher website
Google Scholar
Abstract
No abstract available
Funding Information
  • Boehringer Ingelheim España